Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2641-2650 of 2760 for cancer

Edit search filters
  1. Classification of Breast Masses Using SAVE Method

    Rochester, MN

  2. Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

    Jacksonville, FL

  3. A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

    Rochester, MN

  4. MMRF Molecular Profiling Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Outcomes after Sacroiliac Resection for Pelvic Malignancy

    Rochester, MN

  6. Detection of Circulating Biomarkers (Circulating Tumor Cells and Circulating Tumor DNA) in Patients with Head and Neck Carcinoma following Surgical Intervention

    Scottsdale/Phoenix, AZ

  7. A Study of Using Proton Beam Therapy Which Spares Mucosal Tissue Following the Removal of Oropharyngeal Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Circulating Nucleic Acid Based Biomarkers for Early Detection of Hepatocellular Carcinoma (HCC)

    Jacksonville, FL

  9. Methylation and Chromatin Abnormalities in Myelodysplastic Syndromes and Chronic Myelomonocytic leukemia.

    Rochester, MN

  10. Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

    Rochester, MN

.

Mayo Clinic Footer